Literature DB >> 21728939

A practical approach to the management of lower urinary tract symptoms among men.

Henry H Woo1, Michael P Gillman, Robert Gardiner, Villis Marshall, William J Lynch.   

Abstract

Lower urinary tract symptoms (LUTS) are common among Australian men over the age of 45 years; most men with LUTS will have benign prostatic hyperplasia (BPH), overactive bladder (OAB), or both. The cause of LUTS should be diagnosed by assessing symptom severity and excluding of medical or pharmaceutical causes. All men with LUTS should undergo digital rectal examination; other diagnostic tools include urine and blood testing, voiding charts and imaging. Depending on disease severity, impact on quality of life, patient preference, presence of complications and fitness for surgery, BPH is managed with watchful waiting, pharmacotherapy (α-blockers or 5-α-reductase inhibitors), minimally invasive surgical therapies or surgery. OAB is initially treated with behavioural therapy; if this is ineffective, pharmacotherapy (usually antimuscarinics) can be used. Patients with LUTS with a provisional diagnosis other than BPH or OAB, or with complications or poor response to pharmacotherapy, should be referred to a urologist.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21728939     DOI: 10.5694/j.1326-5377.2011.tb03185.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  6 in total

Review 1.  Drugs for benign prostatic hypertrophy.

Authors:  Manasi Jiwrajka; William Yaxley; Sachinka Ranasinghe; Marlon Perera; Matthew J Roberts; John Yaxley
Journal:  Aust Prescr       Date:  2018-10-01

2.  Evaluation and management of male lower urinary tract symptoms: treatment patterns and guidelines in a correlation study among Polish urology consultants.

Authors:  Tomasz Borkowski; Tomasz Golabek; Piotr L Chlosta; Andrzej Borkowski
Journal:  Arch Med Sci       Date:  2015-12-11       Impact factor: 3.318

3.  Factors related to receipt of non-cancer-related transurethral prostatectomy: findings from a large prospective study of 106 769 middle-aged and older Australian men.

Authors:  Grace Joshy; Kay Soga; Rosemary J Korda; Manish I Patel; Emily Banks
Journal:  BMJ Open       Date:  2017-02-08       Impact factor: 2.692

4.  Undertreatment of overactive bladder among men with lower urinary tract symptoms in the United States: A retrospective observational study.

Authors:  Arthur L Burnett; David R Walker; Qi Feng; Karissa M Johnston; Greta Lozano-Ortega; David Nimke; John C Hairston
Journal:  Neurourol Urodyn       Date:  2020-05-08       Impact factor: 2.696

5.  Efficacy and tolerability of Roystonea regia lipid extract (D-004) and terazosin in men with symptomatic benign prostatic hyperplasia: a 6-month study.

Authors:  Raúl Guzmán; Julio C Fernández; Manuel Pedroso; Lilia Fernández; José Illnait; Sarahí Mendoza; Ana T Quiala; Zunilda Rodríguez; Jilma Mena; Aylim Rodíguez; Marbelis Campos; Carlos Sánchez; Yanet Alvarez; Gladys Jiménez
Journal:  Ther Adv Urol       Date:  2019-06-11

6.  Early experience photoselective vaporisation of the prostate using the 180W lithium triborate and comparison with the 120W lithium triborate laser.

Authors:  Nicholas A Campbell; Amanda S J Chung; Peter D Yoon; Isaac Thangasamy; Henry H Woo
Journal:  Prostate Int       Date:  2013-02-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.